
Screening for type 2 diabetes in primary care
Effectiveness and feasibility of an intensified multifactorial treatment of screen-detected type 2 diabetic patients
Versandkostenfrei!
Versandfertig in 6-10 Tagen
32,99 €
inkl. MwSt.
PAYBACK Punkte
16 °P sammeln!
Diabetes mellitus has become an important health care problem. Its prevalence is worldwide rapidly increasing. A growing body of evidence suggests that earlier diagnosis and treatment of type 2 diabetes may be beneficial. However, definitive evidence is lacking.The studies presented in this book were conducted within the framework of the international ADDITION study (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care), a multicenter, randomised controlled intervention study in screen-detected type 2 diabetic patients. The ADDITION trial has ...
Diabetes mellitus has become an important health
care problem. Its prevalence is worldwide rapidly
increasing. A growing body of evidence suggests that
earlier diagnosis and treatment of type 2 diabetes
may be beneficial. However, definitive evidence is
lacking.
The studies presented in this book were conducted
within the framework of the international ADDITION
study (Anglo-Danish-Dutch Study of Intensive
Treatment in People with Screen-Detected Diabetes in
Primary Care), a multicenter, randomised controlled
intervention study in screen-detected type 2
diabetic patients. The ADDITION trial has been
initiated to evaluate whether screening for
undiagnosed type 2 diabetes is feasible and
subsequent intensified multifactorial treatment is
beneficial.
care problem. Its prevalence is worldwide rapidly
increasing. A growing body of evidence suggests that
earlier diagnosis and treatment of type 2 diabetes
may be beneficial. However, definitive evidence is
lacking.
The studies presented in this book were conducted
within the framework of the international ADDITION
study (Anglo-Danish-Dutch Study of Intensive
Treatment in People with Screen-Detected Diabetes in
Primary Care), a multicenter, randomised controlled
intervention study in screen-detected type 2
diabetic patients. The ADDITION trial has been
initiated to evaluate whether screening for
undiagnosed type 2 diabetes is feasible and
subsequent intensified multifactorial treatment is
beneficial.